| Dr Anna Shender, MD, DO | |
|
66 Glenbrook Rd Ste 400, Stamford, CT 06902 | |
| (203) 961-8241 | |
| Not Available |
| Full Name | Dr Anna Shender |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 66 Glenbrook Rd Ste 400, Stamford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083794812 | NPI | - | NPPES |
| 223637611 | Other | CT | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 000498 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stamford Hospital | Stamford, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Entity Name | Greenwich Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790085983 PECOS PAC ID: 2961699624 Enrollment ID: O20101207000456 |
News Archive
Researchers tested analogs of disulfiram on SARS-CoV-2 Mpro and PLpro to find more efficient and effective inhibitors that take advantage of disulfiram's mechanism of binding to the cysteine residue.
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
A team of researchers from King's College London collaborated with colleagues from China Medical University in Taichung, Taiwan to find that omega-3 fish oil supplements could benefit children with Attention Deficit Hyperactivity Disorder (ADHD). Their work was published in the latest issue of the journal Translational Psychiatry.
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna Shender, MD, DO 66 Glenbrook Rd Ste 400, Stamford, CT 06902 Ph: (203) 961-8241 | Dr Anna Shender, MD, DO 66 Glenbrook Rd Ste 400, Stamford, CT 06902 Ph: (203) 961-8241 |
News Archive
Researchers tested analogs of disulfiram on SARS-CoV-2 Mpro and PLpro to find more efficient and effective inhibitors that take advantage of disulfiram's mechanism of binding to the cysteine residue.
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
A team of researchers from King's College London collaborated with colleagues from China Medical University in Taichung, Taiwan to find that omega-3 fish oil supplements could benefit children with Attention Deficit Hyperactivity Disorder (ADHD). Their work was published in the latest issue of the journal Translational Psychiatry.
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
› Verified 4 days ago
Jeanne M Hosinski, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3 Sweet Briar Rd, Stamford, CT 06905 Phone: 203-968-8101 | |
Dr. Santi J Neuberger, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1290 Summer St, Stamford, CT 06905 Phone: 203-324-9955 Fax: 203-324-0171 | |
Karishma Bellara, PA Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 190 W Broad St, Stamford, CT 06902 Phone: 203-348-2437 Fax: 203-276-7243 | |
Dr. Brian Barry Hennessy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 90 Morgan St, Ste 202, Stamford, CT 06905 Phone: 203-348-2922 Fax: 203-358-8721 | |
Dr. Andreas Bub, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 203-276-7147 | |
Katharine Meyers, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1450 Washington Blvd, Stamford, CT 06902 Phone: 203-327-9321 Fax: 203-967-2140 | |
Dr. Brian Sebastian Wojeck, M.D. M. P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Long Ridge Rd, Stamford, CT 06902 Phone: 203-737-1058 |